H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics

.

Source: Expert Opinion on Therapeutic Targets - February 12, 2023 Category: Drugs & Pharmacology Authors: Julian S. Rechberger Blake T. Power Erica A. Power Cody L. Nesvick David J. Daniels Source Type: research